Education
About Us
Working with TipRanks
Follow Us
Strides Pharma Science Ltd (IN:STAR)
:STAR
Total Valuation
Strides Pharma Science Ltd has a market cap or net worth of ₹83.45B. The enterprise value is ₹100.95B.
Market Cap₹83.45B
Enterprise Value₹100.95B
Share Statistics
Strides Pharma Science Ltd has 92,162,710 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding92,162,710
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Strides Pharma Science Ltd’s return on equity (ROE) is 1.41 and return on invested capital (ROIC) is 31.77%.
Return on Equity (ROE)1.41
Return on Assets (ROA)0.59
Return on Invested Capital (ROIC)31.77%
Return on Capital Employed (ROCE)0.52
Revenue Per Employee15.09M
Profits Per Employee11.72M
Employee Count3,065
Asset Turnover0.76
Inventory Turnover1.55
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio20.6
PS Ratio0.00
PB Ratio3.27
Price to Fair Value21.32
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio1.06
Income Statement
In the last 12 months, Strides Pharma Science Ltd had revenue of 46.24B and earned 35.93B in profits. Earnings per share was 44.05.
Revenue46.24B
Gross Profit26.44B
Operating Income17.81B
Pretax Income4.87B
Net Income35.93B
EBITDA8.62B
Earnings Per Share (EPS)44.05
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Strides Pharma Science Ltd pays an annual dividend of ₹2.5, resulting in a dividend yield of 0.28%
Dividend Per Share₹2.5
Dividend Yield0.28%
Payout Ratio9.33%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.19
52-Week Price Change105.35%
50-Day Moving Average797.03
200-Day Moving Average698.69
Relative Strength Index (RSI)64.64
Average Volume (3m)27.50K
Important Dates
Strides Pharma Science Ltd upcoming earnings date is Jul 30, 2025, TBA (Confirmed).
Last Earnings DateMay 22, 2025
Next Earnings DateJul 30, 2025
Ex-Dividend DateSep 09, 2024
Financial Position
Strides Pharma Science Ltd as a current ratio of 1.20, with Debt / Equity ratio of 73.66%
Current Ratio1.20
Quick Ratio0.70
Debt to Market Cap0.03
Net Debt to EBITDA2.02
Interest Coverage Ratio7.16
Taxes
In the past 12 months, Strides Pharma Science Ltd has paid 775.16M in taxes.
Income Tax775.16M
Effective Tax Rate0.16
Enterprise Valuation
Strides Pharma Science Ltd EV to EBITDA ratio is 65.16, with an EV/FCF ratio of 127.04.
EV to Sales12.14
EV to EBITDA65.16
EV to Free Cash Flow127.04
EV to Operating Cash Flow82.02
Balance Sheet
Strides Pharma Science Ltd has ₹2.06B in cash and marketable securities with ₹18.80B in debt, giving a net cash position of ₹16.73B billion.
Cash & Marketable Securities₹2.06B
Total Debt₹18.80B
Net Cash₹16.73B
Net Cash Per Share₹181.56
Tangible Book Value Per Share₹18.04
Margins
Gross margin is 47.72%, with operating margin of 38.52%, and net profit margin of 77.71%.
Gross Margin47.72%
Operating Margin38.52%
Pretax Margin10.53%
Net Profit Margin77.71%
EBITDA Margin18.63%
EBIT Margin14.47%
Analyst Forecast
The average price target for Strides Pharma Science Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast14.36%
EPS Growth Forecast―